top of page
Image by Jonas Weckschmied
NTMnet Logo neu_edited.png

What we do

NTMnet is an international network to promote clinically oriented research in the field of non- tuberculous mycobacterial diseases around the globe by sharing and developing ideas and research protocols.

Steering Committee

Natalie Lorent.jpg

Natalie Lorent
Chair

is a Pulmonologist/Clinical Infectiologist with a passion for mycobacterial infections. Her work and clinical research focuses on improving diagnosis and care for patients affected by TB/NTM. She has extensive experience in managing TB(HIV) in low-resource settings in Africa and Asia and is currently working at the University Hospitals Leuven, Belgium. Within the TBnet steering committee, she represents NTMnet.

1533227482544.jpeg

Andreas Arnholdt Pedersen
 

is a physician with a special interest in non-tuberculous mycobacterial diseases. He is currently completing a Ph.D. at the Mycobacterial Centre for Research in Southern Denmark, with a focus on the epidemiology and immunology related to NTM. 
Currently, he is undergoing specialized training in infectious diseases at Odense University Hospital, Denmark.

Victor3.jpeg

Victor Næstholt Dahl

is a physician specialising in infectious diseases based in Aarhus Denmark. Victor is interested in respiratory infections particularly tuberculosis and non-tuberculous mycobacteria and mainly works with clinical epidemiology and systematic reviews. He is currently performing a PhD on non-tuberculous mycobacterial infections in Denmark. He is a member of ESCMID Evidence Research Group and ERS Clinical Practice Guidelines Methodology Network aiding with the development of clinical guidelines

Wetzstein.jpg

Nils Wetzstein

is a consultant for infectious diseases at University Hospital Frankfurt (UHF). He has a keen interest in mycobacterial diseases and his research is primarily focussed on NTM infections. The working group of mycobacterial diseases at UHF uses a variety of bacteriological, epidemiological and bioinformatical methods to improve clinical management and patient care for MTB and NTM infected patients.

bottom of page